Answers are grounded in this paper and cite their sources.
Hepatitis C virus is now known to be the causative agent for at least 90% of non-A, non-B hepatitis cases. In the few years since its characterization, much has been learned about this virus and the scope of its disease. It now appears that close to 100% of infections may become chronic, with delayed but potentially devastating consequences. The treatment options for hepatitis C remain limited and less than satisfactory. A vaccine seems to be a distant goal, but other strategies for treatment may be closer. For now, the best option remains prevention.
No takes yet. Share an insight, caveat, or question.
Steven D. Colquhoun (1996) studied this question.
Synapse has enriched 5 related papers. Consider them for comparative context: